CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Glaxo Group Limited v. Genentech, Inc.

2:10-cv-02764

Overview

Case Number 2:10-cv-02764
Filing Date 2010-04-15
Status Terminated
Termination Date 2012-04-03
Court District Court, C.D. California (cacd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Both

Parties

Defendant

Glaxo Group Limited NPE (University / Research)

Represented By

10 Attorneys Listed

Counter Claimant

Lonza Biologics Inc. Operating Company

Represented By

4 Attorneys Listed

Lonza Biologics PLC NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Counter Defendant

GlaxoSmithKline LLC. NPE (University / Research)

Represented By

10 Attorneys Listed

Third Party Plaintiff

Genentech, Inc. Operating Company

Represented By

10 Attorneys Listed

City of Hope NPE (Individual / Inventor)

Represented By

10 Attorneys Listed

Court & Judges

Court

District Court, C.D. California (cacd)

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 8 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 6 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (1): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (14 found):
PTAB: 6 U.S. Courts: 8
USPTO PTAB Trial 2016-10-11
IPR2017-00047

Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-07-07
IPR2016-01373

Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2016-03-03
IPR2016-00710

Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-01-15
IPR2016-00460

Genzyme Corporation et al. v. GENENTECH, INC. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2015-12-30
IPR2016-00383

GENZYME CORPORATION et al. v. Genentech Inc. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2015-07-27
IPR2015-01624

Sanofi-Aventis U.S. LLC et al. v. Genentech, Inc. et al.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2019-04-05
1:19-cv-00638

Genentech, Inc. v. Pfizer Inc.

Asserted Patent
Status: DED
U.S. District Court 2019-03-29
1:19-cv-00602

Genentech, Inc. v. Immunex Rhode Island Corp.

Asserted Patent
Status: DED
U.S. District Court 2018-09-04
1:18-cv-01363

Genentech, Inc. v. Samsung Bioepis Co., Ltd.

Asserted Patent
Status: DED
U.S. District Court 2018-07-11
1:18-cv-11553

GENENTECH, INC. v. CELLTRION, INC.

Asserted Patent
Status: NJD
U.S. District Court 2018-01-12
1:18-cv-00095

Genentech, Inc. v. Celltrion, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-18
1:17-cv-01471

Genentech, Inc. v. Amgen, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-06
1:17-cv-01407

Genentech, Inc. v. Amgen Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-10-01
2:13-cv-07248

Eli Lilly and Company v. Genentech, Inc.

Asserted Patent
Status: CACD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6331415
Filed: โ€”
Issued: โ€”
Term Verification Pending
Expires: โ€”

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. ยง 283) Active Threat

Active Threat โ€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term โ€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. ยง 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

82

Dispositive

58

Granted

14

Denied

0

Pending / Review

67

Motions by Category

Motion to Transfer Venue (28 U.S.C. ยง 1404) 7 Claim Construction / Markman Filing 6 Procedural / Extension Motion 15 Motion to Dismiss 2 Motion to Compel Discovery 2 Motion to Strike / Sanctions 1 Motion for Summary Judgment (Invalidity) 33 Motion for Summary Judgment (Rule 56) 15 Motion for Summary Judgment (Infringement) 1

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Invalidity) Pending / Under Review
ORDER by Judge Mariana R. Pfaelzer: granting 212 Application to file Documents under seal: 1. Glaxo and Lonza's Reply Brief in Support of Their Motions Nos. 1 a...
Entry #215 • 2012-03-19 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
SEALED DOCUMENT- GLAXO and Lonza's REPLY to the Additional Facts in Genentech and City of Hope's Opposition to Motions Nos. 1 and 2 for Summary Judgment of Inva...
Entry #222 • 2012-03-19 Document →
Motion for Summary Judgment (Invalidity) Granted
NOTICE of Manual Filing filed by Plaintiffs Glaxo Group Limited, GlaxoSmithKline LLC., Counter Defendants Glaxo Group Limited, GlaxoSmithKline LLC., Lonza Biolo...
Entry #204 • 2012-03-12 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
APPLICATION for Leave to file documents under seal re Motions Nos. 1 and 2 for Summary Judgment of Invalidity of Claims 1, 3, 11, 12, 14, 15, 17, 19 and 33 for ...
Entry #212 • 2012-03-12 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
APPLICATION to file documents under seal in support of Defendants' Reply Memoranda in support of Motions for Summary Judgment of No Anticipation and as to Extra...
Entry #214 • 2012-03-12 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
SEALED DOCUMENT- REPLY MEMORANDUM in Support of Genentech, Inc. and city of Hope's MOTION for Summary Judgment as to Extraneous Claims and Defenses. (mat) (Ente...
Entry #216 • 2012-03-12 Document →

Docket Entries

(284 total)
Pleading / Complaint

COMPLAINT against City of Hope, Genentech, Inc. ( Filing fee $ 350, receipt number 34611042489, summons issued.). Filed by Glaxo Group Limited, GlaxoSmithKline LLC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(wsn, COURT STAFF) (Filed on 2/17/2010) [Transferred from California Northern on 4/15/2010.] (Entered: 02/18/2010)

Entry #1 • 2010-02-17
1
Pleading / Complaint

COMPLAINT against City of Hope, Genentech, Inc. ( Filing fee $ 350, receipt number 34611042489, summons issued.). Filed by Glaxo Group Limited, GlaxoSmithKline LLC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(wsn, COURT STAFF) (Filed on 2/17/2010) [Transferred from California Northern on 4/15/2010.] (Entered: 02/18/2010)

Entry #1 • 2010-02-17
2
Pleading / Complaint

COMPLAINT against City of Hope, Genentech, Inc. ( Filing fee $ 350, receipt number 34611042489, summons issued.). Filed by Glaxo Group Limited, GlaxoSmithKline LLC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(wsn, COURT STAFF) (Filed on 2/17/2010) [Transferred from California Northern on 4/15/2010.] (Entered: 02/18/2010)

Entry #1 • 2010-02-17
2
Pleading / Complaint

COMPLAINT against City of Hope, Genentech, Inc. ( Filing fee $ 350, receipt number 34611042489, summons issued.). Filed by Glaxo Group Limited, GlaxoSmithKline LLC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(wsn, COURT STAFF) (Filed on 2/17/2010) [Transferred from California Northern on 4/15/2010.] (Entered: 02/18/2010)

Entry #1 • 2010-02-17
2
Court Order

ADR SCHEDULING ORDER: Case Management Statement due by 6/4/2010. Case Management Conference set for 6/11/2010 01:30 PM in Courtroom 2, 17th Floor, San Francisco. (Attachments: # 1 Standing Order, # 2 Standing Order)(wsn, COURT STAFF) (Filed on 2/17/2010) [Transferred from California Northern on 4/15/2010.] (Entered: 02/18/2010)

Entry #2 • 2010-02-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc